Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

34.41
Delayed Data
As of Jun 26
 -0.24 / -0.69%
Today’s Change
24.47
Today|||52-Week Range
36.64
+4.78%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close34.65
Today’s open34.86
Day’s range34.22 - 34.90
Volume221,793
Average volume (3 months)322,477
Market cap$1.4B
Dividend yield--
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+1.73%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio26.3
Price/Sales3.31
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.15+1.16%
CORTCorcept Therapeutics...-0.17-1.36%
FOLDAmicus Therapeutics ...-0.40-3.83%
RGENRepligen Corp+1.14+2.58%
Data as of 06/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts